J. L. Pico

1.2k total citations
23 papers, 894 citations indexed

About

J. L. Pico is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, J. L. Pico has authored 23 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in J. L. Pico's work include Hematopoietic Stem Cell Transplantation (7 papers), Testicular diseases and treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). J. L. Pico is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Testicular diseases and treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). J. L. Pico collaborates with scholars based in France, Italy and Switzerland. J. L. Pico's co-authors include C. Rosenfeld, A Goutner, A.M. Vénuat, M. F. Greaves, B Kayibanda, A. Kramar, J P Droz, Carsten Bokemeyer, W. Siegert and Lawrence H. Einhorn and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

J. L. Pico

23 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. L. Pico France 14 306 282 231 211 174 23 894
J. Casper Germany 17 395 1.3× 374 1.3× 258 1.1× 221 1.0× 109 0.6× 41 970
A Bernadou France 17 180 0.6× 109 0.4× 104 0.5× 192 0.9× 44 0.3× 49 761
Patrizia Lista Italy 12 325 1.1× 69 0.2× 181 0.8× 173 0.8× 67 0.4× 34 735
Gerald L. Messerschmidt United States 12 123 0.4× 111 0.4× 115 0.5× 175 0.8× 32 0.2× 26 559
A. M. Gianni Italy 15 160 0.5× 78 0.3× 109 0.5× 294 1.4× 47 0.3× 26 619
Katsumichi Fujimaki Japan 19 419 1.4× 77 0.3× 171 0.7× 330 1.6× 123 0.7× 85 1.1k
S N Wolff United States 16 1.1k 3.4× 314 1.1× 423 1.8× 863 4.1× 274 1.6× 22 2.1k
Rita Assi United States 13 388 1.3× 157 0.6× 230 1.0× 237 1.1× 165 0.9× 49 824
J. M. Vose United States 15 243 0.8× 51 0.2× 107 0.5× 596 2.8× 80 0.5× 34 1.2k
Robert Golbey United States 17 69 0.2× 347 1.2× 179 0.8× 168 0.8× 112 0.6× 27 666

Countries citing papers authored by J. L. Pico

Since Specialization
Citations

This map shows the geographic impact of J. L. Pico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Pico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Pico more than expected).

Fields of papers citing papers by J. L. Pico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. L. Pico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Pico. The network helps show where J. L. Pico may publish in the future.

Co-authorship network of co-authors of J. L. Pico

This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Pico. A scholar is included among the top collaborators of J. L. Pico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Pico. J. L. Pico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castagna, Luca, E Benhamou, M. Luboinski, et al.. (2001). Prevention of mucositis in bone marrow transplantation: A double blind randomised controlled trial of sucralfate. Annals of Oncology. 12(7). 953–955. 30 indexed citations
2.
Girinsky, T., E Benhamou, J. H. Bourhis, et al.. (2001). Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. Cancer/Radiothérapie. 5(1). 96–97. 1 indexed citations
3.
Blaise, Didier, Michel Attal, Josy Reiffers, et al.. (2000). Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission.. PubMed. 11(1). 91–8. 52 indexed citations
4.
Socié, Gèrard, J Cahn, Vernant Jp, et al.. (1997). Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM). British Journal of Haematology. 97(4). 865–870. 96 indexed citations
5.
6.
Gautier, Élodie, et al.. (1997). Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF. PubMed. 39(2). 85–87. 7 indexed citations
7.
Beyer, J., A. Kramar, Romeo A. Mandanas, et al.. (1996). High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.. Journal of Clinical Oncology. 14(10). 2638–2645. 211 indexed citations
8.
Pico, J. L., et al.. (1993). Escalating High-Dose Carboplatin and Autologous Bone Marrow Transplantation in Solid Tumors. Oncology. 50(2). 47–52. 14 indexed citations
9.
Cosset, J.M., Gèrard Socié, J. L. Pico, et al.. (1993). Prospective Study of the Clinical Symptoms of Therapeutic Whole Body Irradiation. Health Physics. 64(4). 370–374. 22 indexed citations
10.
Droz, J P, J. L. Pico, Mario Ghosn, et al.. (1992). A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.. PubMed. 79(5). 497–507. 26 indexed citations
11.
Droz, Jean‐Pierre, J. L. Pico, Mario Ghosn, et al.. (1991). Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer. European Journal of Cancer and Clinical Oncology. 27(7). 831–835. 36 indexed citations
12.
Hartmann, O, F Beaujean, J. L. Pico, et al.. (1985). Hematopoietic recovery following autologous bone marrow transplantation: Role of cryopreservation, number of cells infused and nature of high-dose chemotherapy. European Journal of Cancer and Clinical Oncology. 21(1). 53–60. 10 indexed citations
13.
Bayssas, M., J. Gouveia, Patricia Ribaud, et al.. (1979). Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas. Cancer Chemotherapy and Pharmacology. 2(4). 247–255. 22 indexed citations
14.
Mathé, G, J. L. Misset, F. de Vassal, et al.. (1978). Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.. PubMed. 62(5). 805–9. 47 indexed citations
15.
Mathé, G, F. de Vassal, L Schwarzenberg, et al.. (1978). Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: Distinction of two groups of patients according to predictable prognosis. Medical and Pediatric Oncology. 4(1). 17–27. 9 indexed citations
16.
Pico, J. L., et al.. (1978). Modifications of lectin binding on human leukemic cells after neuraminidase treatment.. PubMed. 29(2). 75–9. 1 indexed citations
17.
Rosenfeld, C., A Goutner, A.M. Vénuat, et al.. (1977). Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line. Nature. 267(5614). 841–843. 217 indexed citations
18.
Mathé, G, F. de Vassal, L Schwarzenberg, et al.. (1977). Results in children of acute lymphoid leukaemia protocol ICIG-ALL 9 consisting of chemotherapy for only nine months followed by active immunotherapy. Cancer Immunology Immunotherapy. 2(4). 225–232. 4 indexed citations
19.
Mathé, G, François Vassal, L Schwarzenberg, et al.. (1977). Results in Children of Acute Lymphoid Leukemia: Protocol ICIG-ALL 9 Consisting of Chemotherapy for Only 9 Months Followed by Active Immunotherapy. PubMed. 67–77. 3 indexed citations
20.
Rosenfeld, C., A Goutner, A.M. Vénuat, et al.. (1977). An effective human leukaemic cell line: Reh. European Journal of Cancer (1965). 13(4-5). 377–379. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Casper Breakdown of academic impact, for papers by A Bernadou Breakdown of academic impact, for papers by Patrizia Lista Breakdown of academic impact, for papers by Gerald L. Messerschmidt Breakdown of academic impact, for papers by A. M. Gianni Breakdown of academic impact, for papers by Katsumichi Fujimaki Breakdown of academic impact, for papers by S N Wolff Breakdown of academic impact, for papers by Rita Assi Breakdown of academic impact, for papers by J. M. Vose Breakdown of academic impact, for papers by Robert Golbey
Rankless by CCL
2026